Literature DB >> 15833268

Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.

Mazen Kurdi1, Walmor C De Mello, George W Booz.   

Abstract

The renin-angiotensin system (RAS) plays an important role in regulating arterial pressure, blood volume, thirst, cardiac function, and cellular growth. Both a circulating and multiple tissue-localized systems have been identified, and are generally portrayed as a series of reactions that occur sequentially with a single outcome: angiotensinogen is cleaved by renin to form angiotensin I, which in turn is processed by angiotensin-converting enzyme (ACE) to angiotensin II, which then activates either the AT1 or the AT2 plasma membrane receptor. Evidence has emerged, however, showing that some RAS components play important roles outside of this canonical scheme. This article provides an overview of some recently identified extra-system functions. In addition to forming angiotensin II, ACE is a multifunctional enzyme equally important in the metabolism of vasodilator and antifibrotic peptides. As the membrane-bound form, ACE functions as a "receptor" that initiates intracellular signaling leading to gene expression. Both angiotensin I and II may lead to actions that are independent of, or even oppose, those of the RAS via their metabolism by the novel ACE-homologue ACE2. The two angiotensin II receptor types have ligand-independent roles that influence cellular signaling and growth, some of which may result from the ability to form hetero-dimers with other 7-transmembrane receptors. Finally, intracellular angiotensin II has been demonstrated to have actions on cell-communication, gene expression, and cellular growth, through both receptor-dependent and independent means. A greater understanding of these extra-system functions of the RAS components may aid in the development of novel treatments for hypertension, myocardial ischemia, and heart failure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15833268     DOI: 10.1016/j.biocel.2005.01.012

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  22 in total

1.  The one-two punch: knocking out angiotensin II in the heart.

Authors:  Daniela Zablocki; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

2.  Angiotensin II and oxidative stress in the failing heart.

Authors:  Daniela Zablocki; Junichi Sadoshima
Journal:  Antioxid Redox Signal       Date:  2012-05-03       Impact factor: 8.401

3.  Intracrine action of angiotensin II in the intact ventricle of the failing heart: angiotensin II changes cardiac excitability from within.

Authors:  Walmor C De Mello
Journal:  Mol Cell Biochem       Date:  2011-07-09       Impact factor: 3.396

4.  Intracellular angiotensin-(1-12) changes the electrical properties of intact cardiac muscle.

Authors:  W C De Mello; L J Dell'Itallia; J Varagic; C M Ferrario
Journal:  Mol Cell Biochem       Date:  2016-09-02       Impact factor: 3.396

5.  Use of small angle neutron scattering to study the interaction of angiotensin II with model membranes.

Authors:  Julia Preu; Timo Jaeger; Vasil M Garamus; Thomas Gutberlet
Journal:  Eur Biophys J       Date:  2011-02-03       Impact factor: 1.733

6.  Estrogen delays the progression of salt-induced cardiac hypertrophy by influencing the renin-angiotensin system in heterozygous proANP gene-disrupted mice.

Authors:  S Jeson Sangaralingham; M Yat Tse; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2007-08-23       Impact factor: 3.396

7.  Oestrogen and weight loss decrease isoproterenol-induced Fos immunoreactivity and angiotensin type 1 mRNA in the subfornical organ of female rats.

Authors:  Eric G Krause; Kathleen S Curtis; Todd L Stincic; Jason P Markle; Robert J Contreras
Journal:  J Physiol       Date:  2006-03-16       Impact factor: 5.182

8.  Development of an AT2-deficient proximal tubule cell line for transport studies.

Authors:  Philip G Woost; Robert J Kolb; Chung-Ho Chang; Margaret Finesilver; Tadashi Inagami; Ulrich Hopfer
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-10-26       Impact factor: 2.416

9.  Endogenous angiotensinergic system in neurons of rat and human trigeminal ganglia.

Authors:  Hans Imboden; Jaspal Patil; Juerg Nussberger; Françoise Nicoud; Benno Hess; Nermin Ahmed; Thomas Schaffner; Maren Wellner; Dominik Müller; Tadashi Inagami; Takaaki Senbonmatsu; Jaroslav Pavel; Juan M Saavedra
Journal:  Regul Pept       Date:  2009-02-12

Review 10.  Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents?

Authors:  Pei Wang; Matthew N Fedoruk; Jim L Rupert
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.